Blue Square Asset Management, LLC Abb Vie Inc. Transaction History

Blue Square Asset Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $1.42 Million - $1.58 Million	-13,460 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $67,722 - $74,554	662 Added 5.17%	13,460 $1.46 Million
Q4 2020 Feb 08, 2021	SELL	$80.49 - $108.67 $384,420 - $519,007	-4,776 Reduced 27.18%	12,798 $1.37 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $308,760 - $362,383	3,594 Added 25.71%	17,574 $1.54 Million
Q2 2020 Aug 11, 2020	SELL	$73.37 - $98.18 $222,457 - $297,681	-3,032 Reduced 17.82%	13,980 $1.37 Million
Q1 2020 Apr 28, 2020	BUY	$64.5 - $97.79 $532,576 - $807,452	8,257 Added 94.31%	17,012 $1.3 Million
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $111,368 - $139,346	-1,544 Reduced 14.99%	8,755 $775,000
Q3 2019 Nov 08, 2019	BUY	$62.98 - $75.72 $648,631 - $779,840	10,299 New	10,299 $780,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Blue Square Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Blue Square Asset Management, LLC with notifications on news.